oxazolidin-2-one has been researched along with Ataxia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ijiro, T; Kiguchi, S; Yaguchi, A; Yokoyama, A | 1 |
| Abe, Y; Ijiro, T; Kiguchi, S; Yaguchi, A; Yokoyama, A | 1 |
2 other study(ies) available for oxazolidin-2-one and Ataxia
| Article | Year |
|---|---|
Rovatirelin ameliorates motor dysfunction in the cytosine arabinoside-induced rat model of spinocerebellar degeneration via acetylcholine and dopamine neurotransmission.
Topics: Acetylcholine; Animals; Ataxia; Cytarabine; Dopamine; Female; Male; Mice; Oxazolidinones; Pyrrolidines; Rats; Spinocerebellar Degenerations; Synaptic Transmission; Thyrotropin-Releasing Hormone | 2022 |
Ameliorating effect of rovatirelin on the ataxia in rolling mouse Nagoya.
Topics: Animals; Ataxia; Behavior, Animal; Brain; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Female; Glucose; Male; Mice; Oxazolidinones; Pyrrolidines; Spinocerebellar Degenerations; Thyrotropin-Releasing Hormone | 2020 |